Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C13H16ClNO |
Molecular Weight | 237.725 |
Optical Activity | ( + ) |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
InChI
InChIKey=YQEZLKZALYSWHR-ZDUSSCGKSA-N
InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1
Molecular Formula | C13H16ClNO |
Molecular Weight | 237.725 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:13:49 UTC 2023
by
admin
on
Fri Dec 15 16:13:49 UTC 2023
|
Record UNII |
50LFG02TXD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N01AX14
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
||
|
NCI_THESAURUS |
C245
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
||
|
WHO-VATC |
QN01AX14
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
60799
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
ESKETAMINE
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
Esketamine
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
100000089754
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
4468
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
2119365
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
7884
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
DB11823
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
SUB25825
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
DTXSID6047810
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
50LFG02TXD
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
CHEMBL395091
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
33643-46-8
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
50LFG02TXD
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
AB-57
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
182137
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY | |||
|
C81400
Created by
admin on Fri Dec 15 16:13:49 UTC 2023 , Edited by admin on Fri Dec 15 16:13:49 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
RACEMATE -> ENANTIOMER |
|
||
|
TARGET -> INHIBITOR |
Noncompetitive antagonists at the NMDA receptor via binding to an allosteric site distinct from the glutamate-binding site.This receptor is a critical modulator of CNS neurotransmission, and excitability changes produced by ketamine antagonism may explain the drug’s anesthetic and analgesic properties.
ALLOSTERIC INHIBITOR
Ki
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|